Literature DB >> 21920540

Clinical and laboratory biology of childhood acute lymphoblastic leukemia.

William L Carroll1, Elizabeth A Raetz.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21920540     DOI： 10.1016/j.jpeds.2011.08.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  20 in total

1.  MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.

Authors:  Courtney L Jones; Christy M Gearheart; Susan Fosmire; Cristina Delgado-Martin; Nikki A Evensen; Karen Bride; Angela J Waanders; Faye Pais; Jinhua Wang; Teena Bhatla; Danielle S Bitterman; Simone R de Rijk; Wallace Bourgeois; Smita Dandekar; Eugene Park; Tamara M Burleson; Pillai Pallavi Madhusoodhan; David T Teachey; Elizabeth A Raetz; Michelle L Hermiston; Markus Müschen; Mignon L Loh; Stephen P Hunger; Jinghui Zhang; Michael J Garabedian; Christopher C Porter; William L Carroll
Journal:  Blood       Date:  2015-08-31       Impact factor: 22.113

2.  Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

Authors:  Courtney L Jones; Teena Bhatla; Roy Blum; Jinhua Wang; Steven W Paugh; Xin Wen; Wallace Bourgeois; Danielle S Bitterman; Elizabeth A Raetz; Debra J Morrison; David T Teachey; William E Evans; Michael J Garabedian; William L Carroll
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 3.  The promise of Janus kinase inhibitors in the treatment of hematological malignancies.

Authors:  Emilee Senkevitch; Scott Durum
Journal:  Cytokine       Date:  2016-10-27       Impact factor: 3.861

4.  Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia.

Authors:  Nasrin Dehghan-Nayeri; Mostafa Rezaei-Tavirani; Mir Davood Omrani; Ahmad Gharehbaghian; Kourosh Goudarzi Pour; Peyman Eshghi
Journal:  J Cell Commun Signal       Date:  2016-10-24       Impact factor: 5.782

5.  A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia.

Authors:  Tamara B Garcia; Jonathan C Snedeker; Dmitry Baturin; Lori Gardner; Susan P Fosmire; Chengjing Zhou; Craig T Jordan; Sujatha Venkataraman; Rajeev Vibhakar; Christopher C Porter
Journal:  Mol Cancer Ther       Date:  2017-06-27       Impact factor: 6.261

6.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

Review 7.  New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

Authors:  Joanna Pierro; Laura E Hogan; Teena Bhatla; William L Carroll
Journal:  Expert Rev Anticancer Ther       Date:  2017-07-05       Impact factor: 4.512

Review 8.  Therapies on the horizon for childhood acute lymphoblastic leukemia.

Authors:  William L Carroll; Stephen P Hunger
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

9.  The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia.

Authors:  Joanna Pierro; Jason Saliba; Sonali Narang; Gunjan Sethia; Shella Saint Fleur-Lominy; Ashfiyah Chowdhury; Anita Qualls; Hannah Fay; Harrison L Kilberg; Takaya Moriyama; Tori J Fuller; David T Teachey; Kjeld Schmiegelow; Jun J Yang; Mignon L Loh; Patrick A Brown; Jinghui Zhang; Xiaotu Ma; Aristotelis Tsirigos; Nikki A Evensen; William L Carroll
Journal:  Mol Cancer Res       Date:  2020-04-24       Impact factor: 5.852

Review 10.  MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Katarzyna Gębarowska; Anna Mroczek; Jerzy R Kowalczyk; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.